MDA Board approves 37 research grants totaling $8.4 million toward neuromuscular disease research to advance research discoveries and new therapy development in amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease (CMT), Duchenne muscular dyst
Funds raised go towards accelerating research, advancing care, and advocating to empower families living with muscular dystrophy, ALS (aka Lou Gehrig’s disease) and related neuromuscular diseases.
Global leaders will gather at the annual MDA Clinical & Scientific Conference March 3-6, 2024. Presentations will be held in-person in Orlando, Florida and available virtually.